메뉴 건너뛰기




Volumn 118, Issue 18, 2011, Pages 4853-4862

ACCR4 antagonist combined with vaccines induces antigen-specific CD8 + T cells and tumor immunity against self antigens

(23)  Pere, Helene a   Montier, Yves a   Bayry, Jagadeesh b   Quintin Colonna, Francoise a,c   Merillon, Nathalie a   Dransart, Estelle d   Badoual, Cecile a,e   Gey, Alain e   Ravel, Patrice f   Marcheteau, Elie a   Batteux, Frederic g   Sandoval, Federico a   Adotevi, Olivier a,e   Chiu, Christopher h   Garcia, Sylvie i   Tanchot, Corinne a   Lone, Yu Chun j   Ferreira, Luis Carlos k   Nelson, Brad H l   Hanahan, Douglas h   more..


Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYCLOPHOSPHAMIDE; HERMES ANTIGEN; ANTINEOPLASTIC AGENT; AUTOANTIGEN; CANCER VACCINE; CCR4 PROTEIN, MOUSE; IMMUNOLOGIC FACTOR; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

EID: 80855156710     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-329656     Document Type: Article
Times cited : (140)

References (48)
  • 1
    • 74049160009 scopus 로고    scopus 로고
    • Mechanisms maintaining peripheral tolerance
    • Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol. 2010;11(1):21-27.
    • (2010) Nat Immunol , vol.11 , Issue.1 , pp. 21-27
    • Mueller, D.L.1
  • 3
    • 1242295282 scopus 로고    scopus 로고
    • + immunoregulatory T cells: Central players in the arena of peripheral tolerance
    • DOI 10.1016/j.smim.2003.12.003
    • Piccirillo CA, Shevach EM. Naturally-occurring CD4+ CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol. 2004;16(2):81-88. (Pubitemid 38234759)
    • (2004) Seminars in Immunology , vol.16 , Issue.2 , pp. 81-88
    • Piccirillo, C.A.1    Shevach, E.M.2
  • 4
    • 51049083609 scopus 로고    scopus 로고
    • The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: Implications for immunotherapy
    • Lehe C, Ghebeh H, Al-Sulaiman A, et al. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. Cancer Res. 2008;68(15):6350-6359.
    • (2008) Cancer Res , vol.68 , Issue.15 , pp. 6350-6359
    • Lehe, C.1    Ghebeh, H.2    Al-Sulaiman, A.3
  • 5
    • 23044463715 scopus 로고    scopus 로고
    • + helper T cell responses in cancer patients
    • DOI 10.1182/blood-2005-02-0607
    • Nishikawa H, Jager E, Ritter G, Old LJ, Gnjatic S. CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients. Blood. 2005; 106(3):1008-1011. (Pubitemid 41076447)
    • (2005) Blood , vol.106 , Issue.3 , pp. 1008-1011
    • Nishikawa, H.1    Jager, E.2    Ritter, G.3    Old, L.J.4    Gnjatic, S.5
  • 6
    • 30444443314 scopus 로고    scopus 로고
    • Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
    • DOI 10.1182/blood-2005-07-2737
    • Zhou G, Drake CG, Levitsky HI. Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood. 2006;107(2):628-636. (Pubitemid 43076387)
    • (2006) Blood , vol.107 , Issue.2 , pp. 628-636
    • Zhou, G.1    Drake, C.G.2    Levitsky, H.I.3
  • 7
    • 68149155982 scopus 로고    scopus 로고
    • Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
    • Peggs KS, Quezada SA, Chambers CA, Korman AJ, Allison JP. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J Exp Med. 2009;206(8): 1717-1725.
    • (2009) J Exp Med , vol.206 , Issue.8 , pp. 1717-1725
    • Peggs, K.S.1    Quezada, S.A.2    Chambers, C.A.3    Korman, A.J.4    Allison, J.P.5
  • 12
    • 33947655511 scopus 로고    scopus 로고
    • + regulatory T cells
    • Bayry J, Triebel F, Kaveri SV, Tough DF. Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells. J Immunol. 2007;178(7):4184-4193. (Pubitemid 46492369)
    • (2007) Journal of Immunology , vol.178 , Issue.7 , pp. 4184-4193
    • Bayry, J.1    Triebel, F.2    Kaveri, S.V.3    Tough, D.F.4
  • 13
    • 33645067654 scopus 로고    scopus 로고
    • Regulatory T cells inhibit stable contacts between CD4+T cells and dendritic cells in vivo
    • Tadokoro CE, Shakhar G, Shen S, et al. Regulatory T cells inhibit stable contacts between CD4+T cells and dendritic cells in vivo. J Exp Med. 2006;203(3):505-511.
    • (2006) J Exp Med , vol.203 , Issue.3 , pp. 505-511
    • Tadokoro, C.E.1    Shakhar, G.2    Shen, S.3
  • 14
    • 48249150707 scopus 로고    scopus 로고
    • In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination
    • Bayry J, Tchilian EZ, Davies MN, et al. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc Natl Acad Sci U S A. 2008;105(29):10221-10226.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , Issue.29 , pp. 10221-10226
    • Bayry, J.1    Tchilian, E.Z.2    Davies, M.N.3
  • 15
    • 77951239027 scopus 로고    scopus 로고
    • Toward the discovery of vaccine adjuvants: Coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors
    • Davies MN, Bayry J, Tchilian EZ, et al. Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors. PLoS One. 2009;4(11):e8084.
    • (2009) PLoS One , vol.4 , Issue.11
    • Davies, M.N.1    Bayry, J.2    Tchilian, E.Z.3
  • 17
    • 16444377935 scopus 로고    scopus 로고
    • + T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer
    • DOI 10.1158/0008-5472.CAN-04-3444
    • Daniel D, Chiu C, Giraudo E, et al. CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer. Cancer Res. 2005;65(5):2018-2025. (Pubitemid 40478632)
    • (2005) Cancer Research , vol.65 , Issue.5 , pp. 2018-2025
    • Daniel, D.1    Chiu, C.2    Giraudo, E.3    Inoue, M.4    Mizzen, L.A.5    Chu, N.R.6    Hanahan, D.7
  • 18
    • 34447119507 scopus 로고    scopus 로고
    • Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells
    • DOI 10.1158/0008-5472.CAN-07-0622
    • Wall EM, Milne K, Martin ML, Watson PH, Theiss P, Nelson BH. Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells. Cancer Res. 2007; 67(13):6442-6450. (Pubitemid 47037529)
    • (2007) Cancer Research , vol.67 , Issue.13 , pp. 6442-6450
    • Wall, E.M.1    Milne, K.2    Martin, M.L.3    Watson, P.H.4    Theiss, P.5    Nelson, B.H.6
  • 19
    • 15244354286 scopus 로고    scopus 로고
    • Regulatory T cell lineage specification by the forkhead transcription factor Foxp3
    • DOI 10.1016/j.immuni.2005.01.016
    • Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22(3):329-341. (Pubitemid 40387475)
    • (2005) Immunity , vol.22 , Issue.3 , pp. 329-341
    • Fontenot, J.D.1    Rasmussen, J.P.2    Williams, L.M.3    Dooley, J.L.4    Farr, A.G.5    Rudensky, A.Y.6
  • 20
    • 33646569995 scopus 로고    scopus 로고
    • The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity
    • Vingert B, Adotevi O, Patin D, et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur J Immunol. 2006;36(5):1124-1135.
    • (2006) Eur J Immunol , vol.36 , Issue.5 , pp. 1124-1135
    • Vingert, B.1    Adotevi, O.2    Patin, D.3
  • 21
    • 38049021296 scopus 로고    scopus 로고
    • B sub-unit of Shiga toxin-based vaccines synergize with {alpha}-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity
    • Adotevi O, Vingert B, Freyburger L, et al. B sub-unit of Shiga toxin-based vaccines synergize with {alpha}-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity. J Immunol. 2007;179(5):3371-3379.
    • (2007) J Immunol , vol.179 , Issue.5 , pp. 3371-3379
    • Adotevi, O.1    Vingert, B.2    Freyburger, L.3
  • 22
    • 28944442195 scopus 로고    scopus 로고
    • Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1
    • DOI 10.1016/j.micinf.2005.05.024, PII S1286457905002443
    • Lasaro MO, Diniz MO, Reyes-Sandoval A, Ertl HC, Ferreira LC. Anti-tumor DNA vaccines based on the expression of human papillomavirus- 16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1. Microbes Infect. 2005;7(15):1541-1550. (Pubitemid 41785728)
    • (2005) Microbes and Infection , vol.7 , Issue.15 , pp. 1541-1550
    • Lasaro, M.O.1    Diniz, M.O.2    Reyes-Sandoval, A.3    Ertl, H.C.4    Ferreira, L.C.S.5
  • 23
    • 41149178490 scopus 로고    scopus 로고
    • Comparative methodologies of regulatory T cell depletion in a murine melanoma model
    • Matsushita N, Pilon-Thomas SA, Martin LM, Riker AI. Comparative methodologies of regulatory T cell depletion in a murine melanoma model. J Immunol Methods. 2008;333(1-2):167-179.
    • (2008) J Immunol Methods , vol.333 , Issue.1-2 , pp. 167-179
    • Matsushita, N.1    Pilon-Thomas, S.A.2    Martin, L.M.3    Riker, A.I.4
  • 27
    • 78649890647 scopus 로고    scopus 로고
    • Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice
    • Reboulet RA, Hennies CM, Garcia Z, Nierkens S, Janssen EM. Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice. J Immunol. 2010;185(6):3337-3347.
    • (2010) J Immunol , vol.185 , Issue.6 , pp. 3337-3347
    • Reboulet, R.A.1    Hennies, C.M.2    Garcia, Z.3    Nierkens, S.4    Janssen, E.M.5
  • 28
    • 0034665096 scopus 로고    scopus 로고
    • The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens
    • Haicheur N, Bismuth E, Bosset S, et al. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol. 2000;165(6):3301-3308.
    • (2000) J Immunol , vol.165 , Issue.6 , pp. 3301-3308
    • Haicheur, N.1    Bismuth, E.2    Bosset, S.3
  • 29
    • 33747891558 scopus 로고    scopus 로고
    • Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance
    • DOI 10.1158/0008-5472.CAN-06-1432
    • Ambrosino E, Spadaro M, Iezzi M, et al. Immuno-surveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance. Cancer Res. 2006;66(15): 7734-7740. (Pubitemid 44289233)
    • (2006) Cancer Research , vol.66 , Issue.15 , pp. 7734-7740
    • Ambrosino, E.1    Spadaro, M.2    Iezzi, M.3    Curcio, C.4    Forni, G.5    Musiani, P.6    Wei, W.-Z.7    Cavallo, F.8
  • 30
    • 58249111461 scopus 로고    scopus 로고
    • Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice
    • Radkevich-Brown O, Jacob J, Kershaw M, Wei WZ. Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice. Cancer Res. 2009;69(1):212-218.
    • (2009) Cancer Res , vol.69 , Issue.1 , pp. 212-218
    • Radkevich-Brown, O.1    Jacob, J.2    Kershaw, M.3    Wei, W.Z.4
  • 31
    • 33744925146 scopus 로고    scopus 로고
    • Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu/-expressing tumor cells in vivo
    • DOI 10.1158/0008-5472.CAN-05-4018
    • Gritzapis AD, Mahaira LG, Perez SA, Cacoullos NT, Papamichail M, Baxevanis CN. Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo. Cancer Res. 2006;66(10):5452-5460. (Pubitemid 43844973)
    • (2006) Cancer Research , vol.66 , Issue.10 , pp. 5452-5460
    • Gritzapis, A.D.1    Mahaira, L.G.2    Perez, S.A.3    Cacoullos, N.T.4    Papamichail, M.5    Baxevanis, C.N.6
  • 32
    • 62449250053 scopus 로고    scopus 로고
    • Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome
    • Gobert M, Treilleux I, Bendriss-Vermare N, et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009;69(5):2000-2009.
    • (2009) Cancer Res , vol.69 , Issue.5 , pp. 2000-2009
    • Gobert, M.1    Treilleux, I.2    Bendriss-Vermare, N.3
  • 33
    • 34247120690 scopus 로고    scopus 로고
    • - Tregs, regulate effector T cells using FasL
    • Baatar D, Olkhanud P, Sumitomo K, Taub D, Gress R, Biragyn A. Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL. J Immunol. 2007; 178(8):4891-4900. (Pubitemid 46595271)
    • (2007) Journal of Immunology , vol.178 , Issue.8 , pp. 4891-4900
    • Baatar, D.1    Olkhanud, P.2    Sumitomo, K.3    Taub, D.4    Gress, R.5    Biragyn, A.6
  • 35
    • 35548950221 scopus 로고    scopus 로고
    • Regulatory T-cell inhibition versus depletion: The right choice in cancer immunotherapy
    • DOI 10.1038/nrc2250, PII NRC2250
    • Colombo MP, Piconese S. Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy. Nat Rev Cancer. 2007;7(11): 880-887. (Pubitemid 350006256)
    • (2007) Nature Reviews Cancer , vol.7 , Issue.11 , pp. 880-887
    • Colombo, M.P.1    Piconese, S.2
  • 36
    • 66249095192 scopus 로고    scopus 로고
    • Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer model
    • Wada S, Yoshimura K, Hipkiss EL, et al. Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Res. 2009;69(10):4309-4318.
    • (2009) Cancer Res , vol.69 , Issue.10 , pp. 4309-4318
    • Wada, S.1    Yoshimura, K.2    Hipkiss, E.L.3
  • 37
    • 50949115267 scopus 로고    scopus 로고
    • Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
    • Morse MA, Hobeika AC, Osada T, et al. Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. Blood. 2008;112(3):610-618.
    • (2008) Blood , vol.112 , Issue.3 , pp. 610-618
    • Morse, M.A.1    Hobeika, A.C.2    Osada, T.3
  • 39
    • 27444435581 scopus 로고    scopus 로고
    • 389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma
    • Attia P, Maker AV, Haworth LR, Rogers-Freezer L, Rosenberg SA. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J Immunother. 2005;28(6):582-592. (Pubitemid 41533092)
    • (2005) Journal of Immunotherapy , vol.28 , Issue.6 , pp. 582-592
    • Attia, P.1    Maker, A.V.2    Haworth, L.R.3    Rogers-Freezer, L.4    Rosenberg, S.A.5
  • 40
    • 36148939150 scopus 로고    scopus 로고
    • IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
    • DOI 10.1182/blood-2007-06-094615
    • Litzinger MT, Fernando R, Curiel TJ, Grosenbach DW, Schlom J, Palena C. IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood. 2007;110(9):3192-3201. (Pubitemid 350106311)
    • (2007) Blood , vol.110 , Issue.9 , pp. 3192-3201
    • Litzinger, M.T.1    Fernando, R.2    Curiel, T.J.3    Grosenbach, D.W.4    Schlom, J.5    Palena, C.6
  • 44
    • 17144393320 scopus 로고    scopus 로고
    • + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor
    • DOI 10.1084/jem.20041709
    • Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med. 2005;201(7):1037-1044. (Pubitemid 40524671)
    • (2005) Journal of Experimental Medicine , vol.201 , Issue.7 , pp. 1037-1044
    • Lee, I.1    Wang, L.2    Wells, A.D.3    Dorf, M.E.4    Ozkaynak, E.5    Hancock, W.W.6
  • 45
    • 77949830320 scopus 로고    scopus 로고
    • Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
    • Semmling V, Lukacs-Kornek V, Thaiss CA, et al. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol. 2010;11(4):313-320.
    • (2010) Nat Immunol , vol.11 , Issue.4 , pp. 313-320
    • Semmling, V.1    Lukacs-Kornek, V.2    Thaiss, C.A.3
  • 46
    • 67650638846 scopus 로고    scopus 로고
    • T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
    • Di Stasi A, De Angelis B, Rooney CM, et al. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood. 2009;113(25):6392-6402.
    • (2009) Blood , vol.113 , Issue.25 , pp. 6392-6402
    • Di Stasi, A.1    De Angelis, B.2    Rooney, C.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.